Monthly Archives: August 2019

Fang Holdings Ltd. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 30, 2019 / Fang Holdings Ltd. (NYSE: SFUN) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on August 30, 2019 at 8:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/C-ED4FB1607899B

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 557926

Creative Biolabs Gets Ready to Accelerate Customers’ Complement Therapeutics Projects

Creative Biolabs launches a full scope of complement therapeutic services and complement based drug discovery services for global clients.

Shirley, United States – August 30, 2019 /MarketersMedia/

With years of extensive exposure to the field of complement system, Creative Biolabs is capable of serving the clients on a worldwide scale. Relative complement therapeutic services base upon the complement system cover therapeutic antibodies, protease inhibitors, soluble complement regulators, complement component inhibitors and anaphylatoxin receptor antagonists, which can be customized catering to a variety of laboratory standards and requirements, so as to help clients discover novel drugs, avoid the pitfalls of variability in assays and benefit from the efficiency and accuracy of a dedicated facility.

1.Tailored Services of Complement System
The complement system plays a significant role both in the innate immunity and adaptive immune response due to its competence of coordinating immune reactions, which functions in phagocytosis, inflammation and membrane attack. Creative Biolabs provides relevant customizable services covering the classical, lectin, alternative pathways, and membrane attack complex.

Service Range:
Classical Complement Pathway: C1 Complex, C1 Inhibitor, C2, C3, C4, C5, C5aR complement
Lectin Complement Pathway: MASP-1, MASP-2
Alternative Pathway: Complement Factor B, Complement Factor D, Complement Factor P
Membrane Attack Complex: C6, C7, C8, C9 complement

2.Solutions to Therapeutic Antibody Development
Creative Biolabs’s technical experts have successfully established the proprietary complement therapeutics system, looking forward to designing a strategy to carry on the therapeutic antibodies development services for clients in complement therapeutics.

Service Highlight:
C5 complement antibody designed to bind C5 specifically, and attack pro-inflammatory immune cells; inhibit C5 selectively using monoclonal antibodies (mAb) to improve the therapeutic effects.
CD20 complement antibody (other names: Complement component 5) facilitates the complement-directed drug discovery and development, for example, a human mAb targeting an epitope encompassing the membrane-proximal small-loop on the CD20 molecule.
CD46 complement antibody targets at CD46 (MCP), a type 1 transmembrane glycoprotein, and supplements the therapeutic exploration as a crucial target.
CD55 complement antibody takes effects on the decay-accelerating factor (DAF), assisting with the relative drug exploration with clinical significance.
CD59 complement antibody is perfectly developed to take aim at the GPI-anchored membrane protein, CD59 (other names: MAC-inhibitory protein (MAC-IP), membrane inhibitor of reactive lysis (MIRL)) that functions as the regulator of complement activation and in the proliferation of T cells to produce cytokines.

For years, Creative Biolabs has been committed to the one-stop services concerning about the complement therapeutics working on the complementary system, which operate upon the advanced technology platforms. Other complement therapeutic services stay available to fulfill every possible need of clients, covering the serine protease inhibitors, soluble complement regulators, complement component inhibitors, anaphylatoxin receptor antagonists, etc. For details accordingly, please feel free to visit https://www.creative-biolabs.com/complement-therapeutics/.

About the company
Creative Biolabs is a leading global biologics company established in the New York, United States in 2004. With more than 10 years of exploration and expansion, Creative Biolabs has demonstrated reliable expertise and capability in the biotech/pharmaceutical market and expanded the research and service capacity to the full pipeline of drug discovery and development industries.

Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Address: 45-1 Ramsey Road
Phone: 1-631-619-7922
Website: https://www.creative-biolabs.com/complement-therapeutics/

Source URL: https://marketersmedia.com/creative-biolabs-gets-ready-to-accelerate-customers-complement-therapeutics-projects/88913850

Source: MarketersMedia

Release ID: 88913850

Creative Biolabs Provides Comprehensive Services of Stem Cell Therapy Development

Creative Biolabs is offering a full set of stem cell therapy development services internationally, intending to accelerate the growth of Stem Cell Therapy (SCT) around the world, and hence to facilitate new drug discovery and manufacturing.

Shirley, United States – August 30, 2019 /MarketersMedia/

Stem cells are non-specialized cells holding the ability to switch to many different types of cells, which therefore play a key role in the body’s healing process and the stem cell regenerative medicine (also known as Stem Cell Therapy). Aiming to improve the pharmaceutical process of STC on a worldwide scale, Creative Biolabs, built up by a group of scientists, is devoted to providing comprehensive services and products accordingly. The one-stop solutions contain basic research services, stem cell therapy development services and stem cell manufacturing, and featured products cover the STEMODTM disease models.

Services Coverage

The experienced scientists offer all-round GMP compliant basic research services regarding the whole stage of stem cell therapy to ensure safe, pure, and efficient drug products for clients, which include services of Induced Pluripotent Stem Cells (iPSC), Mesenchymal Stem Cells (MSCs), Organoid and 3D Bioprinting, Genome Editing for Stem Cell, and Assay Development.

Core package—MSCs services: Creative Biolabs offers cutting-edge cell therapy research services covering every stage of MSC development, involving isolation, expansion, characterization, and differentiation, featured with the following highlights:

The provided cells from clients stay ensured for long-term viability, multipotent potential, integrity, and uniformity.
Adjustable services to guarantee varied requirements according to cellular applications and assay endpoints are satisfied.
Abundant desired-function cell populations plus perfect culture insurance

The SCT development solutions possess the capability of developing stem cell treatment development, whose products reveal significance to the growth, maintenance and repair of organs like brain, bone, muscle, nerve, blood, skin, etc., with stem cells adopted to develop customized disease modeling. Services in this section contain disease-specific stem cell therapy development, iPSC-derived cell therapy development, and stem cell facilitated drug discovery.

The following stem cell manufacturing services are still under continuous development with the joint efforts of experts from Creative Biolabs, in the aim of perfecting all the clients’ projects countering diversified objectives.

MSC Expansion Services
ES Expansion Services
Stem Cell Differentiation Services
Characterization Services
Cell Labeling Services
Cell Banking Services

The study on stem cells in the US can be traced back to the 150, which initially revealed hope to the treatment of cancer that such cells were capable of differentiating. That discovery was a boom in the medical area and till now, the SCT, iPSC, MSC research occupies the strategic location and is moving forward to the improvement of current disease therapies and drug development. “Our intention is to assist the research institutes and pharmaceutical manufacturing,” said the head of Creative Biolabs, which has been endeavoring in the SCT field for years, conscientiously and professionally. For more information about the stem cell therapy development, please feel free to visit https://www.creative-biolabs.com/stem-cell-therapy/.

About the Company
Creative Biolabs is a whole-hear one-stop solutions provider working on stem cell therapy development with a history of more than a decade. There still exist huge challenges in gene and cell therapy before new approaches (iPSC cell technology) can enter mainstream medicine. With years of experience in providing high-quality products and services in the field of biopharmaceuticals for customers all over the world, scientists in Creative Biolabs will be more focused on developing first-class product and technology to meet the need of stem cell therapy development.

Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Address: 45-1 Ramsey Road
Phone: 1-631-619-7922
Website: https://www.creative-biolabs.com/stem-cell-therapy/

Source URL: https://marketersmedia.com/creative-biolabs-provides-comprehensive-services-of-stem-cell-therapy-development/88913852

Source: MarketersMedia

Release ID: 88913852

Creative Biolabs is Offering High-throughput Sequencing Services for Cancer Worldwide

Creative Biolabs provides a full set of cancer research relevant sequencing services, aiming to assist medical researchers with solving biological issues and understanding the molecular mechanisms of many diseases including human cancers.

Shirley, United States – August 30, 2019 /MarketersMedia/

Creative Biolabs has been dedicated to improving the human cancer diagnosis and precision medicine from a biomedical perspective, offering sequencing solutions with experienced scientists and advanced technology platform—SuPrecision™ Platform, on which the services can be operable include but are not confined to Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing, Whole Transcriptome Sequencing (WTS), Immune Repertoire Sequencing (Rep-seq), Bioinformatics Analysis, etc.

Whole Genome Sequencing (WGS)
As the core propeller for various medical researches, whole genome sequencing constitutes a crucial part in the cancer research projects and complex genetic malfunction. The service is capable of undertaking germline variant detection, somatic variant detection, whole genome re-sequencing, de novo genome assembly, copy number variation, structural variant discovery, and so on. The whole workflow of WGS starts from experimental design, and then followed by library preparation, sequencing, and finally to genomics analysis to ensure 99.99% accurate result.
Applications: capturing large/small variants; identifying unknown genes; obtaining high-standard de novo assemblies; identifying the change of genetic predisposition; providing information for specialized cancer treatment plans.

Whole Exome Sequencing (WES)
Creative Biolabs owns extensive experience accumulated in Whole Exome Sequencing program associated with corresponding WES Bioinformatic Analysis, in the field of next-generation sequencing (NGS). Equipped with the state of the art SuPrecision™ Platform, the WES for cancer enables experimental design, library preparation & exome enrichment, sequencing, and variant calling & downstream analysis, guaranteeing various variants identification, comprehensive coding region coverage, and quick turnaround.
Applications: tumor mutational burden (TMB) analysis; variants analysis; structural variants detection; copy-number variation analysis; tumor-specific neoantigen identification, etc.

Whole Transcriptome Sequencing (WTS)
The whole transcriptome sequencing services cover more than mRNA sequencing (miRNA/CircRNA/LncRNA/Exosome RNA sequencing are also available.), which are offered in the aim of improving the messenger RNA transcriptome sequencing (mRNA-Seq) to a powerful support for researching disease transcription. The WTS solutions hold the competence of investigating all possible RNAs from known to novel, detecting new and rare transcripts/transcript variants, enabling long read lengths for low expressed full-length transcripts, and allowing the study of isoforms, splice variants and fusion transcripts. The corresponding transcriptome analysis stands as a supplement to meet every customer’s requirements as it should be.
Applications: library preparation; high-throughput sequencing; bioinformatics analysis.

“We hope to optimize your research process on personalized medicine with our NGS services,” said the head of Creative Biolabs. Services provided for cancer research, aside from the above-introduced ones, also compose comprehensive bioinformatic analysis solutions. Having been working on a large number of NGS projects for years, valuable data and experience accumulate simultaneously, which will consummate global customers’ projects efficiently. For details regarding the next-generation sequencing services, please visit https://www.creative-biolabs.com/suprecision/.

About the Company
Creative Biolabs, since the establishment in 2004, has been regarded as the leading service provider in the area of next-generation sequencing (NGS). Holding the extensive exploration experience, the scientists built a comprehensive SuPrecision™ Platform to provide precise and high throughput sequencing services especially for cancer.

Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Address: 45-1 Ramsey Road
Phone: 1-631-619-7922
Website: https://www.creative-biolabs.com/suprecision/

Source URL: https://marketersmedia.com/creative-biolabs-is-offering-high-throughput-sequencing-services-for-cancer-worldwide/88913845

Source: MarketersMedia

Release ID: 88913845

Go Limitless Announced as Official Design Partner for Mowden Park’s 2019/20 Season

Go Limitless is delighted to announce a new partnership with Mowden Park, working as their official design partner for the 2019/2020 season.

August 30, 2019 / /

Go Limitless is an award winning website, marketing and design agency based in Darlington in the North East of England. They are dedicated to delivering results through innovation and creativity and love taking on new challenges. Now, the company is thrilled to announce that they have been selected as the official design partner for Mowden’s Park for the 2019/2020 season.

Partnering with Mowden Park is a brilliant opportunity for Go Limitless to showcase their unparalleled design and ability to create impactful promotional campaigns. Managing Director at Go Limitless, Matt Prosser, said: “This partnership with Mowden Park over the next season is going to be a really exciting one. With plenty of great projects and developments on the horizon for both ourselves and Mowden Park, it is going to be a pleasure supporting and working with everyone in the Mowden Park team.”

Go Limitless offers a wide range of services including website design, graphic design, branding, SEO, Facebook and Google ad management and business printing. Some of their best work has come about by combining various services to create a comprehensive marketing strategy tailored to their client. However, it is their ethos focusing on client care ad building relationships that really sets the Go Limitless brand apart.

The opportunity to work with a fast-growing local business, like Go Limitless, is also an attractive prospect for Mowden Park. Nick Saint, head of Commercial at Mowden Park, said: “We’re really pleased to have Go Limitless join the Mowden Family as our Official Design Partner for the upcoming season. They are a growing company with ambitions that match our own, and we very much look forward to working with them going forward.”

2019/20 is already set to be an exciting season but teaming up with Mowden Park is a great indicator for the continued growth of Go Limitless over the last four years. The team are already brimming with brilliant ideas and are looking forward to getting started on the project together.

For more information about Go Limitless, please contact Matt Prosser on 01325 526503, or email info@golimitless.co.uk. Please address any postal queries to Yarn Suite 7, Lingfield House, Darlington, DL1 1RW and check out their website https://golimitless.co.uk for any further information you need.

Contact Info:
Name: Matt Prosser
Email: Send Email
Organization: Go Limitless
Address: Yarn Suite 7, Lingfield House, Darlington, DL1 1RW
Phone: 01325 526503
Website: https://golimitless.co.uk

Source:

Release ID: 88913880

Steamaster Expands Distribution of Truvox Cleaning Equipment Across Australia

Steamaster, a wholesaler providing state-of-the-art cleaning equipment, accessories and chemicals, is pleased to announce that they are now distributing Truvox Cleaning Equipment.

August 30, 2019 / /

Steamaster is the perfect business partner for cleaning businesses around Australia. They offer state-of-the-art cleaning equipment, accessories and chemicals as well as advertising templates and an incredible service. In other words, Steamaster provides all the support cleaning businesses in Australia need to thrive.

Now, Steamaster is pleased to announce that they will be adding Truvox cleaning equipment to their fantastic range of products, giving their clients even more choice and many more options to suit their business’ needs.

Truvox International is a leading supplier of industrial and commercial floor cleaning machines and cleaning equipment, based in Southampton, UK. Their products meet the needs of a wide range of industries from healthcare to retail and are a great fit for Steamaster’s clients too. Their products are packed full of innovative solutions and simple but effective designs to make cleaning easy. For example, their multiwash accessories significantly reduce the chance of cross-contamination between areas and are even fully compliant with the NHS’s colour-coding scheme.

Managing Director for Steamaster, Tam Le, said, “as we are constantly looking for ways to expand and improve our services, we’re very excited to announce that Steamaster is now an official Australian distributor of Truvox Floor Scrubbers and Cleaning Equipment.”

Truvox’s comprehensive range of single disc rotaries, which include machines for stripping, scrubbing wet and dry polishing and shampooing are particularly good for Steamaster’s clients. They are versatile, economical and powerful enough for the toughest floor maintenance demands so they work well in a range of settings and in a range of industries too.

Truvox International is recognised in over 70 countries and Steamaster is delighted to be able to distribute their products in Australia. Bringing Truvox products to Australia is a really exciting opportunity for Steamaster but it is also a demonstration of their commitment to providing the very best products in the industry at affordable prices. The hardwearing nature of Truvox products also sets them apart, offering businesses a long lasting solution and a worthy investment.

For more information about Steamaster, please contact Tam Le on 1300 855 677, or email tam@steamaster.com.au. Please address any postal queries to 6 Reservoir Ave, Greenacre NSW 2190 and check out their website https://www.steamaster.com.au/ for any further information you need.

Contact Info:
Name: Tam Le
Email: Send Email
Organization: Steamaster
Address: 6 Reservoir Ave, Greenacre NSW 2190
Phone: 1300 855 677
Website: https://www.steamaster.com.au/

Source:

Release ID: 88913878

V1 Group Presented Significant Improvement for its Interim Results Performance of Crazy Sport Exceeded Expectations

HONG KONG / ACCESSWIRE / August 30, 2019 / V1 Group Limited (“V1 Group” or the “Group”; stock code: 00082.HK) today announced the interim results of the Group for the six months ended 30 June 2019 (the “Reporting Period” or the “Period”). During the Reporting Period, the Group maintained steady development of its business performance and business sectors despite the global economic downturn. For the six months ended 30 June 2019, the Group recorded unaudited revenue of over HK$1.2 billion. Gross profit for the Period was over HK$70 million, compared to a gross loss recorded in the same period last year, successfully achieving a turnaround, and far exceeded the industry average. The full acquisition of Fengkuang Tiyu (“Crazy Sport”) generated great potential for the Group’s revenue and the business became the main profit growth driver for the Group during the Period.

Loss saw significant reduction while main business achieved a turnaround from loss to profit to contribute net profit
During the Period, V1 Group recorded gross profit of over HK$70 million, achieving a significant reduction in losses compared to the same period last year. The Group’s major businesses achieved a turnaround in gross profit. During the Period, Crazy Sport contributed over HK$30 million in gross profit and became one of the largest online sports communities in the country. Liangzi Gang (“量子港”) recorded a substantial increase in gross profit margin. Liangzi Gang has become an Apple T2 authorised dealer during the Period.

Performance of Crazy Sport exceeded expectations with strong growth momentum in both revenue and profit
The Group completed the full acquisition of Crazy Sport last year. During the Period, Crazy Sport continued to cultivate its position in the sports industry. In the first half of 2019, it exceeded expectations and completed 60% of the guaranteed profit as stated in the acquisition document, showing growth in both revenue and profit.

By business sector, the monthly average revenue per user (ARPU) of sports live broadcasting showed a 3.5 times growth, while the number of daily active anchors and total number showed a threefold and fivefold increase respectively. The Crazy Recommendation (“瘋狂紅單”) mobile App provides paid information services for sports lottery players. It has achieved outstanding performance in the paid lottery knowledge sector by expanding the lottery analyst team, comprehensively upgrading sports lottery analysis tools and exploring traffic cooperation channels. As a senior business partner for official games of the Chinese Super League, Crazy Sport makes good use of its advantages to record a total revenue of more than RMB100 million and secure more than 1 million sports game users during the Period.

Based on the Group’s development strategy, in the second half of the year, Crazy Sport will continue to focus on the sports industry and forge a business ecosystem for its “Video +” sports community.

V1 Group’s overall business revenue remained stable and satisfactory; well-deployed management strategy led to good results
Dr. ZHANG Lijun, Chairman and Executive Director of V1 Group Limited, said, “The Group kept up its momentum in the less-than-ideal investment environment and maintained a stable, satisfactory overall business development. This showed that our strategy of ‘business streamlining, deployment adjustment, and video focused’ for the video business is taking effect. In the future, we will further implement the integrated development strategy, and seize the opportunities brought by 5G technology to improve our new media matrix. With video news community, video sports community, and video new retail e-commerce as spearheads, we will continue to focus on our major businesses and strive to develop into a smart Internet enterprise”

About V1 Group Limited
Founded in 2005, V1 Group Limited became a listed company on the Main Board of the Hong Kong Stock Exchange in 2006, and is the first China online video company to be listed in Hong Kong. The Group has a “Video+” business focus. Supported by 5G technology, it aims to build an ecosystem around news video community, sports video community and video new retail. In 2016, V1 Group successfully transformed from a new media enterprise into an internet-based new economy entity. Leveraging on its diverse business covering the media, connected living, internet financing, advanced internet technology as well as other sectors, the Group has become one of the top 100 internet companies in China. the Company made a full acquisition of Fengkuang Tiyu (“Crazy Sport”) in 2018 to accelerate the construction of its “Video+” sports community business model, creating a strong overall revenue growth momentum for the Group.

For more information, please visit ir.v1group.com.hk.

Contact:
V1 Group Limited
Sidney Tsui
sidneytsui@vodone.com.hk
http://www.v1group.com/

SOURCE: V1 Group Ltd

ReleaseID: 557976

Arlington TX Fish Stocking Dallas Trophy Bass Lake Electrofishing Surveys Launch

Bryan, Texas lake management and fish stocking company Lochow Ranch Pond & Lake Management announced the availability of cutting-edge electrofishing for lake owners looking for an accurate assessment of their fish populations.

Bryan, United States – August 30, 2019 /NewsNetwork/

Lochow Ranch Pond & Lake Management, a lake management company based in Bryan, Texas, announced an updated range of services for lake owners looking for professional fish stocking, population analysis and management solutions. The company uses state-of-the-art electrofishing technology to determine fish species, abundance, population density, and other essential fishery characteristics, using the data to create a long-term lake management plan and take any necessary measures to address potential issues.

More details can be found at http://www.lochowranch.com.

Electrofishing is a standard scientific survey method designed to survey the fish population in a body of water. By briefly stunning the fish, it allows the experts to gather important data such as fish species, weight, health, growth rate and population density without harming the fish.

Lochow Ranch Pond & Lake Management uses a cutting-edge electrofishing boat to accurately assess fish populations and, if necessary, remove invasive or foreign species. This ensures optimal fish balance in a body of water, especially after heavy rains or floods.

The company works with expert biologists, technicians and other experts to ensure high standards of safety and quality, and create a personalized lake management and fish stocking plan adapted to the specific ecosystem of each lake.

Lochow Ranch Pond & Lake Management serves clients in Dallas, Arlington, Tyler, McKinney and throughout Texas, as well as in Oklahoma, Arkansas and Louisiana.

A spokesperson for the company said: “At Lochow Ranch, we’re proud of our ponds. By delivering comprehensive pond and lake management services to all of Texas, our team of professionals ensures the quality of our work and takes care in every step to ensure your pond’s health. Whether you’re looking for a crystal blue lake, a trophy bass fishery, or a fly fishing paradise, we work with you to understand your individual needs and build the best solution for you.”

Interested parties can find more information by visiting the above-mentioned website and by viewing this company video: https://youtu.be/s5rNrt64OvI

Contact Info:
Name: John Jones
Email: Send Email
Organization: Lochow Ranch Pond & Lake Management
Address: 7571 N State Hwy 6, Bryan, Texas 77807, United States
Phone: +1-866-422-9022
Website: http://lochowranch.com

Source: NewsNetwork

Release ID: 88903905

Dialysis Equipment Market Strategy and Remarkable Growth Rate by 2025

Dialysis Equipment Market summarized details by key players are Nikkiso Co., Ltd., Fresenius Medical Care, Toray Medical Co. Ltd., Baxter, JMS Co. Ltd., B Braun Melsungen, Asahi Kasei Corporation, Nipro Corporation, and more

Pune, India – August 30, 2019 /MarketersMedia/

The global dialysis equipment market is likely to gain momentum from the rising prevalence of chronic kidney disease and end-stage renal disease in the coming years. Fortune Business Insights, in a published report, titled “Dialysis Equipment: Global Market Analysis, Insights and Forecast, 2017-2025,” states that the global dialysis equipment market is projected to reach US$ 22,405.4 Mn by 2025, exhibiting a CAGR of 5.1% in the forecast period. The market was valued at US$ 15,092.0 Mn in 2017. There has been an increase in the share of the healthcare expenditure by several enterprises to treat chronic kidney disease and end-stage renal disease. This is likely to cause a rise in the global dialysis equipment market sales during the forecast period.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/dialysis-equipment-market-101252

Fortune Business Insights has profiled some of the leading companies operating in the Global Dialysis Equipment Market

• Nikkiso Co., Ltd.
• Fresenius Medical Care
• Toray Medical Co. Ltd.
• Baxter
• JMS Co. Ltd.
• B Braun Melsungen
• Asahi Kasei Corporation
• Nipro Corporation, and other prominent market players.

The report classifies the global dialysis equipment market on the bases of equipment type, end user, and geography. In terms of equipment type, the market is divided into hemodialysis equipment and peritoneal dialysis equipment. Out of these, the hemodialysis equipment segment currently leads the global market. However, Fortune Business Insights predicts that the peritoneal dialysis equipment segment will witness growth during the forecast period. This will occur because unlike hemodialysis equipment, the peritoneal equipment offers a reduction in the cost of treatment, high level of patient comfort, and advanced operating flexibility. By end user, the market is categorized into home healthcare and dialysis centers and hospitals.

Rising Cases of Kidney Failure and Diabetes to Favor Growth in North America

The global dialysis equipment market is geographically segmented into Asia Pacific, Latin America, the Middle East and Africa, Europe, and North America. Amongst these, Asia Pacific had generated US$ 5,573.0 Mn in 2017 in terms of revenue. The region is anticipated to remain in the dominant position throughout the forecast period. This is likely to occur due to a rise in the awareness programs regarding dialysis and the increasing prevalence of end-stage renal disease.

North America is projected to follow the footsteps of Asia Pacific and remain in the second position. The rising cases of hypertension, diabetes, and kidney failure are anticipated to be the major factors driving the dialysis equipment market growth in this region. Europe will also witness notable growth due to the region’s progressive enterprises and technologically advanced healthcare infrastructure.

Get Sample PDF Brochure at https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dialysis-equipment-market-101252

STRONG INDUSTRY FOCUS:

• Extensive product offerings
• Customer research services
• Robust research methodology
• Comprehensive reports
• Latest technological developments
• Value chain analysis
• Potential market oppertunities
• Growth dynamics
• Quality assurance
• Post-sales support
• Regular report updates

Baxter, Fresenius, and Other Prominent Key Players Focus on Gaining FDA Approvals and Plant Expansion to Increase Sales

Baxter International Inc., a prominent health care company, headquartered in the U.S., announced that the company has received FDA approval for its multicenter and prospective clinical trial in January 2019. The trial will be held to test the company’s new on-demand PD generation system that is expected to ease a patient’s experience through use at home. The trial will evaluate the safety and effectiveness of the latest technology which makes use of a small water filtration device. It aids in turning tap water to dialysis solution in order to complete the patient’s therapy session.

Earlier, in September 2017, Fresenius Medical Care, a provider of kidney dialysis services, based in Germany, announced that the company has expanded its regional manufacturing plant in Bandar Enstek located in Malaysia. This new plant will be a state-of-the-art facility that will remain a manufacturing hub for Southeast Asia. It will aid in supplying high quality hemodialysis disinfectants and concentrates. It will also produce peritoneal dialysis products that are required for advanced Continuous Ambulatory PD treatment. Malaysia possesses strategic geographic location, a skilled workforce, and positive business environment. Hence, the company chose the region to build its manufacturing plant.

Get Discount at https://www.fortunebusinessinsights.com/enquiry/check-discount/dialysis-equipment-market-101252

Major Table of Content

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of End-Stage Renal Disease
4.2. The Prevalence of Chronic Kidney Disease
4.3. Recent Industry Developments Such as Mergers & Acquisitions
4.4. The Regulatory Scenario in Key Countries
4.5. Key Industry Trends
5. Global Dialysis Equipment Market Analysis, Insights and Forecast, 2014-2025

TOC Continued……!

More Trending Topics from Fortune Business Insights:

Ultrasound Equipment Market 2019 Share, Size, Regional Trend, Future Growth, Current and Future Plans by Forecast to 2025

Digital Radiography Market 2019 Size, Global Trends, Development Status, Opportunities, Future Plans, Competitive Landscape and Growth by Forecast 2025

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Ashwin Arora
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd., 308, Supreme Headquarters,, Survey No. 36, Baner,, Pune-Bangalore Highway,, Pune – 411045, Maharashtra, India.
Phone: 4242530390
Website: https://www.fortunebusinessinsights.com/industry-reports/dialysis-equipment-market-101252

Source URL: https://marketersmedia.com/dialysis-equipment-market-strategy-and-remarkable-growth-rate-by-2025/88913871

Source: MarketersMedia

Release ID: 88913871

Raleigh NC Mold Remediation & Removal Air Quality Inspection Services Launched

Raleigh Mold updated its range of mold remediation services for residential clients in Raleigh. The team will find the cause & fix it to ensure long-lasting protection against future mold growth.

Apex, United States – August 30, 2019 /PressCable/

Raleigh Mold, an Apex, North Carolina, based company specialized in full-service mold and indoor air quality, announced the launch of an updated range of mold inspection, remediation, and removal services for clients in Raleigh, Cary, Chapel Hill, Holly Springs, Sanford and the surrounding areas. The company has over 20 years of business experience in residential, commercial and multi-family home improvement and mold inspection.

More information can be found at http://www.raleighmold.com

Mold is one of the most common and persistent problems in homes, offices, and other buildings. Mold can trigger health problems and bring severe damage to one’s home or business.

The certified experts at Raleigh Mold offer fast and reliable inspection, testing and remediation services for mold, today’s most common indoor air pollutant.

If a property has a strange moisture area that owners cannot identify, the inspection experts use leading-edge equipment to determine the problem and offer reasonable solutions. These may include air purification units, surface protection products, and mold removal.

The team’s experience ensures that all moisture and mold problems will be identified quickly and efficiently. They understand and respect each client’s need for quality service, safety and affordability, and that is why they use the latest technology and tools, while continuing to expand their credentials and list of services.

With the recent announcement, Raleigh Mold is committed to providing North Carolina residents and business owners with top-of-the-line mold inspection and removal services that ensure their property is free of mold and other indoor air pollutants.

A satisfied client said: “I had an urgent issue with mold in my bedroom vent. Upon contact they were able to do a same-day inspection and issue a very reasonable quote. I did not feel that they charged me more resulting from the urgency. Two days later they executed the work. They were on time, on budget and extremely professional. Will be relying on them in the future if new issues arise.”

Interested parties can find more by visiting the above-mentioned website.

Raleigh Mold

300 Satinwood Dr, Apex, NC 27502

Walter Smith

sales@raleighmold.com

+1 919-410-6653

Contact Info:
Name: Walter Smith
Email: Send Email
Organization: Raleigh Mold
Address: 300 Satinwood Dr, Apex, NC 27502, United States
Phone: +1-919-410-6653
Website: http://www.raleighmold.com/

Source: PressCable

Release ID: 88913078